<?xml version="1.0" encoding="UTF-8"?>
<p id="par0150">As tried during the 2014â€“2015 Ebola outbreak, the use of the plasma of a recovered patient can provide polyclonal antibodies to different viral antigens of SARS-CoV-2, which can help treat patients who contract the virus later by providing a neutralizing effect and increasing the immune response of the patient. However, there are limitations in the speed and scope of such a development 
 <xref rid="bib0375" ref-type="bibr">[75]</xref>.
</p>
